Marc Machaalani

16PUBLICATIONS
128CO-AUTHORS
Molecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 25, 2026
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.

|Apr 28, 2026
The clinical landscape of HIF2α inhibitors in oncology.

|Jan 28, 2026
Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer.

Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao

|Jan 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund

|Jan 07, 2026
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Carolina Alves Costa Silva, Marc Machaalani, Renee Maria Saliby

|Dec 19, 2025
Molecular and clinical insights of trastuzumab deruxtecan efficacy in advanced breast cancer.

Amin H Nassar, Elias Bou Farhat, Hassan Abushukair

Pageof 3

Frequent Collaborators

13 joint publications

Toni K Choueiri

4 joint publications

Eddy Saad

4 joint publications

William G Kaelin

3 joint publications

Kei Enomoto